ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/08/28 | 3,730 | 3,730 | 3,670 | 3,685 | -25 | -0.7% | 131,200 |
2018/08/27 | 3,715 | 3,715 | 3,685 | 3,710 | +5 | +0.1% | 167,100 |
2018/08/24 | 3,710 | 3,730 | 3,680 | 3,705 | +5 | +0.1% | 104,800 |
2018/08/23 | 3,710 | 3,715 | 3,680 | 3,700 | -5 | -0.1% | 119,800 |
2018/08/22 | 3,680 | 3,720 | 3,665 | 3,705 | +30 | +0.8% | 147,500 |
2018/08/21 | 3,655 | 3,690 | 3,650 | 3,675 | +35 | +1% | 190,600 |
2018/08/20 | 3,680 | 3,695 | 3,625 | 3,640 | -35 | -1% | 190,300 |
2018/08/17 | 3,595 | 3,680 | 3,590 | 3,675 | +65 | +1.8% | 188,400 |
2018/08/16 | 3,635 | 3,645 | 3,595 | 3,610 | -25 | -0.7% | 178,600 |
2018/08/15 | 3,645 | 3,665 | 3,595 | 3,635 | -70 | -1.9% | 239,200 |
2018/08/14 | 3,680 | 3,735 | 3,670 | 3,705 | +30 | +0.8% | 199,500 |
2018/08/13 | 3,680 | 3,710 | 3,625 | 3,675 | -40 | -1.1% | 289,900 |
2018/08/10 | 3,710 | 3,740 | 3,690 | 3,715 | -10 | -0.3% | 274,700 |
2018/08/09 | 3,745 | 3,755 | 3,720 | 3,725 | -45 | -1.2% | 249,700 |
2018/08/08 | 3,760 | 3,795 | 3,745 | 3,770 | +20 | +0.5% | 356,700 |
2018/08/07 | 3,785 | 3,790 | 3,720 | 3,750 | -105 | -2.7% | 253,900 |
2018/08/06 | 3,915 | 3,920 | 3,850 | 3,855 | -65 | -1.7% | 250,500 |
2018/08/03 | 3,795 | 3,920 | 3,675 | 3,920 | +355 | +10% | 741,100 |
2018/08/02 | 3,640 | 3,655 | 3,555 | 3,565 | -75 | -2.1% | 145,200 |
2018/08/01 | 3,620 | 3,650 | 3,600 | 3,640 | +15 | +0.4% | 136,300 |
2018/07/31 | 3,685 | 3,700 | 3,620 | 3,625 | -20 | -0.5% | 289,100 |
2018/07/30 | 3,670 | 3,675 | 3,605 | 3,645 | ±0 | ±0% | 133,000 |
2018/07/27 | 3,610 | 3,660 | 3,595 | 3,645 | +45 | +1.3% | 190,200 |
2018/07/26 | 3,530 | 3,605 | 3,510 | 3,600 | +100 | +2.9% | 161,600 |
2018/07/25 | 3,540 | 3,540 | 3,490 | 3,500 | -35 | -1% | 217,100 |
2018/07/24 | 3,565 | 3,565 | 3,520 | 3,535 | -25 | -0.7% | 169,700 |
2018/07/23 | 3,555 | 3,605 | 3,555 | 3,560 | -15 | -0.4% | 146,000 |
2018/07/20 | 3,555 | 3,575 | 3,530 | 3,575 | -30 | -0.8% | 242,500 |
2018/07/19 | 3,630 | 3,635 | 3,595 | 3,605 | -25 | -0.7% | 156,500 |
2018/07/18 | 3,585 | 3,635 | 3,585 | 3,630 | +65 | +1.8% | 160,900 |
2018/07/17 | 3,505 | 3,575 | 3,495 | 3,565 | +65 | +1.9% | 197,500 |
2018/07/13 | 3,465 | 3,505 | 3,445 | 3,500 | +25 | +0.7% | 177,800 |
2018/07/12 | 3,485 | 3,510 | 3,465 | 3,475 | ±0 | ±0% | 171,500 |
2018/07/11 | 3,470 | 3,490 | 3,425 | 3,475 | -5 | -0.1% | 199,500 |
2018/07/10 | 3,525 | 3,540 | 3,480 | 3,480 | -40 | -1.1% | 201,600 |
2018/07/09 | 3,505 | 3,520 | 3,470 | 3,520 | +50 | +1.4% | 147,300 |
2018/07/06 | 3,455 | 3,490 | 3,445 | 3,470 | +5 | +0.1% | 197,700 |
2018/07/05 | 3,500 | 3,500 | 3,445 | 3,465 | -30 | -0.9% | 180,100 |
2018/07/04 | 3,475 | 3,515 | 3,475 | 3,495 | +5 | +0.1% | 126,700 |
2018/07/03 | 3,455 | 3,520 | 3,440 | 3,490 | +5 | +0.1% | 229,100 |
2018/07/02 | 3,550 | 3,560 | 3,475 | 3,485 | -95 | -2.7% | 199,700 |
2018/06/29 | 3,590 | 3,590 | 3,540 | 3,580 | -5 | -0.1% | 206,500 |
2018/06/28 | 3,635 | 3,650 | 3,570 | 3,585 | -50 | -1.4% | 183,600 |
2018/06/27 | 3,640 | 3,655 | 3,605 | 3,635 | -70 | -1.9% | 198,600 |
2018/06/26 | 3,655 | 3,715 | 3,635 | 3,705 | +40 | +1.1% | 152,700 |
2018/06/25 | 3,710 | 3,710 | 3,660 | 3,665 | -70 | -1.9% | 127,400 |
2018/06/22 | 3,755 | 3,770 | 3,720 | 3,735 | -60 | -1.6% | 219,300 |
2018/06/21 | 3,815 | 3,870 | 3,790 | 3,795 | -50 | -1.3% | 185,900 |
2018/06/20 | 3,875 | 3,880 | 3,785 | 3,845 | -45 | -1.2% | 346,800 |
2018/06/19 | 3,965 | 3,995 | 3,890 | 3,890 | -80 | -2% | 232,000 |
1651~
1700
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 407,800円 | +5.8% | +1.2% | 2.94% | 13.52倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム